The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 11,966 | 1,536,016 | SH | OTR | 1,536,016 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 18,584 | 831,495 | SH | OTR | 831,495 | 0 | 0 | ||
ALIGOS THERAPEUTICS | COM | 01626L105 | 23,669 | 1,526,048 | SH | OTR | 1,526,048 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 22,204 | 2,325,000 | SH | OTR | 2,325,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 35,256 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 72,700 | 2,084,883 | SH | OTR | 2,084,883 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 51,620 | 170,926 | SH | OTR | 170,926 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 5,220 | 1,500,000 | SH | OTR | 1,500,000 | 0 | 0 | ||
ATRECA INC | CL A COM | 04965G109 | 13,721 | 2,202,333 | SH | OTR | 2,202,333 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 27,618 | 1,121,327 | SH | OTR | 1,121,327 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 4,980 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 277,400 | 764,188 | SH | OTR | 764,188 | 0 | 0 | ||
BELLUS HEALTH INC | COM NEW | 07987C204 | 18,267 | 2,975,000 | SH | OTR | 2,975,000 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 20,206 | 686,347 | SH | OTR | 686,347 | 0 | 0 | ||
BIOMEA FUSION INC | COM CL A | 09077A106 | 24,998 | 2,088,405 | SH | OTR | 2,088,405 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS INC | COM | 09203E105 | 17,046 | 2,014,858 | SH | OTR | 2,014,858 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 43,694 | 425,000 | SH | OTR | 425,000 | 0 | 0 | ||
CABALETTA BIO INC | COM | 12674W109 | 19,497 | 1,603,361 | SH | OTR | 1,603,361 | 0 | 0 | ||
CELLECTAR BIOSCIENCES INC | COM PAR | 15117F500 | 851 | 920,000 | SH | OTR | 920,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 22,282 | 1,334,227 | SH | OTR | 1,334,227 | 0 | 0 | ||
CODIAK BIOSCIENCES INC | COM | 192010106 | 16,821 | 1,030,065 | SH | OTR | 1,030,065 | 0 | 0 | ||
CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 50,430 | 2,081,323 | SH | OTR | 2,081,323 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 24,242 | 1,074,082 | SH | OTR | 1,074,082 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 75,054 | 2,100,000 | SH | OTR | 2,100,000 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS INC | COM | 23954D109 | 28,237 | 1,189,943 | SH | OTR | 1,189,943 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 36,920 | 7,534,598 | SH | OTR | 7,534,598 | 0 | 0 | ||
DIREXION SHS ETF TR | DAILY S&P BIOTEC | 25460G716 | 3,195 | 150,000 | SH | OTR | 150,000 | 0 | 0 | ||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 10,451 | 1,341,530 | SH | OTR | 1,341,530 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 9,549 | 450,000 | SH | OTR | 450,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 5,496 | 687,000 | SH | OTR | 687,000 | 0 | 0 | ||
F-STAR THERAPEUTICS INC | COM | 30315R107 | 12,820 | 1,751,428 | SH | OTR | 1,751,428 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 35,263 | 1,250,000 | SH | OTR | 1,250,000 | 0 | 0 | ||
GEMINI THERAPEUTICS INC | COM | 36870G105 | 5,252 | 1,300,000 | SH | OTR | 1,300,000 | 0 | 0 | ||
GENOCEA BIOSCIENCES INC | COM NEW | 372427401 | 2,178 | 1,134,453 | SH | OTR | 1,134,453 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 22,356 | 1,013,399 | SH | OTR | 1,013,399 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 30,952 | 2,462,358 | SH | OTR | 2,462,358 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,956 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 3,980 | 400,000 | SH | OTR | 400,000 | 0 | 0 | ||
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 56,150 | 2,202,812 | SH | OTR | 2,202,812 | 0 | 0 | ||
IMMUTEP LTD | SPONSORED ADS | 45257L108 | 9,675 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
IOVANCE BIOTHERAPETUICS INC | COM | 462260100 | 27,126 | 1,100,000 | SH | OTR | 1,100,000 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 117,315 | 4,345,016 | SH | OTR | 4,345,016 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 4,875 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 3,310 | 290,577 | SH | OTR | 290,577 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 42,531 | 1,847,559 | SH | OTR | 1,847,559 | 0 | 0 | ||
KURA ONCOLOGY INC. | COM | 50127T109 | 19,672 | 1,050,289 | SH | OTR | 1,050,289 | 0 | 0 | ||
LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 3,554 | 890,700 | SH | OTR | 890,700 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 1,960 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 27,312 | 2,400,000 | SH | OTR | 2,400,000 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 8,040 | 2,913,091 | SH | OTR | 2,913,091 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 41,800 | 1,900,000 | SH | OTR | 1,900,000 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS INC | COM | 59935V107 | 14,687 | 2,572,194 | SH | OTR | 2,572,194 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 353,820 | 2,000,000 | SH | OTR | 2,000,000 | 0 | 0 | ||
MODERNA INC | PUT | 60770K957 | 253 | 10,000 | SH | Put | OTR | 10,000 | 0 | 0 | |
NUVALENT INC | COM | 670703107 | 27,290 | 1,210,192 | SH | OTR | 1,210,192 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 4,605 | 750,000 | SH | OTR | 750,000 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 10,853 | 1,501,058 | SH | OTR | 1,501,058 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 10,510 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 36,698 | 1,224,892 | SH | OTR | 1,224,892 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 43,150 | 4,341,009 | SH | OTR | 4,341,009 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 683 | 266,666 | SH | OTR | 266,666 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 16,317 | 5,607,086 | SH | OTR | 5,607,086 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 1,947 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 4,182 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP II | CL A SHS | G6882C106 | 4,885 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
PASSAGE BIO INC | COM | 702712100 | 19,206 | 1,928,315 | SH | OTR | 1,928,315 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 67,593 | 2,268,236 | SH | OTR | 2,268,236 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 19,225 | 2,500,000 | SH | OTR | 2,500,000 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 1,448 | 209,227 | SH | OTR | 209,227 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 21,369 | 300,000 | SH | OTR | 300,000 | 0 | 0 | ||
RAIN THERAPEUTICS INC | COM | 75082Q105 | 17,578 | 1,175,000 | SH | OTR | 1,175,000 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 40,804 | 1,294,132 | SH | OTR | 1,294,132 | 0 | 0 | ||
RESEARCH ALLIANCE CORP II | COM CL A | 760873109 | 4,925 | 500,000 | SH | OTR | 500,000 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 95,852 | 3,484,264 | SH | OTR | 3,484,264 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 43,820 | 1,466,051 | SH | OTR | 1,466,051 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 48,475 | 1,094,000 | SH | OTR | 1,094,000 | 0 | 0 | ||
SELECTA BIOSCIENCES INC | COM | 816212104 | 13,662 | 3,284,072 | SH | OTR | 3,284,072 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 16,720 | 1,675,377 | SH | OTR | 1,675,377 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 8,926 | 3,734,574 | SH | OTR | 3,734,574 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 131,695 | 2,075,905 | SH | OTR | 2,075,905 | 0 | 0 | ||
SURROZEN INC | COM | 86889P109 | 1,416 | 200,000 | SH | OTR | 200,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 43,720 | 2,287,782 | SH | OTR | 2,287,782 | 0 | 0 | ||
TALIS BIOMEDICAL CORP | COM | 87424L108 | 9,694 | 1,550,998 | SH | OTR | 1,550,998 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 88,850 | 6,871,642 | SH | OTR | 6,871,642 | 0 | 0 | ||
TURNING POINT THERAPEUTICS INC | COM | 90041T108 | 34,876 | 525,000 | SH | OTR | 525,000 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 111,228 | 6,323,359 | SH | OTR | 6,323,359 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 7,277 | 450,000 | SH | OTR | 450,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 13,095 | 857,000 | SH | OTR | 857,000 | 0 | 0 |